UBS Group’s Tevogen Bio Holdings TVGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $101K | Sell |
81,120
-102,738
| -56% | -$128K | ﹤0.01% | 5965 |
|
2025
Q1 | $199K | Sell |
183,858
-753
| -0.4% | -$813 | ﹤0.01% | 5323 |
|
2024
Q4 | $190K | Buy |
184,611
+174,031
| +1,645% | +$179K | ﹤0.01% | 5280 |
|
2024
Q3 | $3.89K | Buy |
10,580
+3,941
| +59% | +$1.45K | ﹤0.01% | 6994 |
|
2024
Q2 | $4.8K | Buy |
+6,639
| New | +$4.8K | ﹤0.01% | 6891 |
|
2023
Q4 | – | Sell |
-147
| Closed | -$1.6K | – | 8632 |
|
2023
Q3 | $1.6K | Buy |
+147
| New | +$1.6K | ﹤0.01% | 6738 |
|
2023
Q2 | – | Sell |
-720
| Closed | -$7.77K | – | 8516 |
|
2023
Q1 | $7.77K | Buy |
720
+620
| +620% | +$6.69K | ﹤0.01% | 6682 |
|
2022
Q4 | $1.03K | Sell |
100
-100
| -50% | -$1.03K | ﹤0.01% | 8782 |
|
2022
Q3 | $2K | Hold |
200
| – | – | ﹤0.01% | 8683 |
|
2022
Q2 | $2K | Buy |
+200
| New | +$2K | ﹤0.01% | 8589 |
|